Until recently, Michal served as Regional Head of Johnson & Johnson Innovation, East North America. In this role, she led the J&J team in sourcing, evaluating, and executing partnerships and investment deals with the most promising early-stage healthcare innovations in the region, with the goal of advancing them into J&J’s product pipelines to benefit patients. Previously, Michal held senior leadership roles at Harvard University, overseeing technology development and strategic partnerships at Harvard Medical School. There, she initiated, negotiated, and managed numerous high-impact industry licenses and alliances, helped launch successful startups, and contributed to a cultural shift toward scientific entrepreneurship among faculty and trainees. Earlier in her career, Michal held executive roles in the biotech and tech industries, including at Compugen Ltd (NASDAQ: CGEN). During her current brief sabbatical, Michal remains active in the innovation ecosystem, among other by serving on the Board of Directors of MassBio and the Kendall Square Association (KSA). She holds MSc and PhD degrees from the Weizmann Institute of Science and an MBA from INSEAD.